The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings
Abstract
BACKGROUND: Baseline information on human papillomavirus (HPV) prevalence and type distribution is highly desirable to evaluate the impact of prophylactic HPV vaccines in the near future. METHODS: A meta-analysis was performed of studies published between 1995 and 2009 that used polymerase chain reaction or Hybrid Capture 2 for HPV detection in women with normal cytological findings. RESULTS: The analysis included 194 studies comprising 1,016,719 women with normal cytological findings. The estimated global HPV prevalence was 11.7% (95% confidence interval, 11.6%-11.7%). Sub-Saharan Africa (24.0%), Eastern Europe (21.4%), and Latin America (16.1%) showed the highest prevalences. Age-specific HPV distribution presented with a first peak at younger ages (<25 years) and, in the Americas and Africa, a rebound at older ages (≥45 years). Among the women with type-specific HPV data (n = 215,568), the 5 most common types worldwide were HPV-16 (3.2%), HPV-18 (1.4%), HPV-52 (0.9%), HPV-31 (0.8%), and HPV-58 (0.7%). CONCLUSIONS: Although the prevalence of HPV in women with normal cytological findings is high and variable across world regions, HPV types 16, 18, 31, 52, and 58 are consistently found among the 10 most common types in all of them. These results represent the most comprehensive assessment of HPV burden among women with normal cytological findings in the pre-HPV vaccination era worldwide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., & Unger, E. R. (2007) · PsycEXTRA Dataset · doi:10.1037/e601292007-001 · Cited by 1,882
de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Self-citationHPV Screening for Cervical Cancer in Rural India
Sankaranarayanan, R., Nene, B. M., Shastri, S. S., Jayant, K., Muwonge, R., Budukh, A. M., Hingmire, S., Malvi, S. G., Thorat, R., Kothari, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808516 · Cited by 1,278
Clifford, G., Gallus, S., Herrero, R., Muñoz, N., Snijders, P., Vaccarella, S., Anh, P., Ferreccio, C., Hieu, N., Matos, E., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67069-9 · Cited by 1,093
Self-citationSexual behaviour in context: a global perspective
Wellings, K., Collumbien, M., Slaymaker, E., Singh, S., Hodges, Z., Patel, D., & Bajos, N. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69479-8 · Cited by 933
Bosch, F. X., Burchell, A. N., Schiffman, M., Giuliano, A. R., de Sanjose, S., Bruni, L., Tortolero-Luna, G., Kjaer, S. K., & Muñoz, N. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.064 · Cited by 842
Self-citationKleter, B., van Doorn, L.-J., Schrauwen, L., Molijn, A., Sastrowijoto, S., ter Schegget, J., Lindeman, J., ter Harmsel, B., Burger, M., & Quint, W. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.8.2508-2517.1999 · Cited by 655
Moscicki, A.-B. (2001) · JAMA · doi:10.1001/jama.285.23.2995 · Cited by 557
Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
Rodriguez, A. C., Schiffman, M., Herrero, R., Wacholder, S., Hildesheim, A., Castle, P. E., Solomon, D., Burk, R., & On behalf of the Proyecto Epidemiologico Guanacaste Group (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn044 · Cited by 549
PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems
Qu, W., Jiang, G., Cruz, Y., Chang, C. J., Ho, G. Y., Klein, R. S., & Burk, R. D. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1304-1310.1997 · Cited by 463
Variations in the age‐specific curves of human papillomavirus prevalence in women worldwide
Franceschi, S., Herrero, R., Clifford, G. M., Snijders, P. J. F., Arslan, A., Anh, P. T. H., Bosch, F. X., Ferreccio, C., Hieu, N. T., Lazcano‐Ponce, E., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22241 · Cited by 415
Self-citationCastle, P. E., Schiffman, M., Herrero, R., Hildesheim, A., Rodriguez, A. C., Bratti, M. C., Sherman, M. E., Wacholder, S., Tarone, R., & Burk, R. D. (2005) · The Journal of Infectious Diseases · doi:10.1086/428779 · Cited by 403
Muñoz, N., Méndez, F., Posso, H., Molano, M., van den Brule, A. J. C., Ronderos, M., Meijer, C., Muñoz, Á., & Instituto Nacional de Cancerología HPV study group (2004) · The Journal of Infectious Diseases · doi:10.1086/425907 · Cited by 395
Age-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
Smith, J. S., Melendy, A., Rana, R. K., & Pimenta, J. M. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.07.009 · Cited by 377
Herrero, R., Castle, P. E., Schiffman, M., Bratti, M. C., Hildesheim, A., Morales, J., Alfaro, M., Sherman, M. E., Wacholder, S., Chen, S., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428850 · Cited by 377
Epidemiology of HPV infection among Mexican women with normal cervical cytology
Lazcano‐Ponce, E., Herrero, R., Muñoz, N., Cruz, A., Shah, K. V., Alonso, P., Hernández, P., Salmerón, J., & Hernández, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010201)91:3<412::aid-ijc1071>3.0.co;2-m · Cited by 324
Snijders, P. J., van den Brule, A. J., & Meijer, C. J. (2003) · The Journal of Pathology · doi:10.1002/path.1433 · Cited by 278
Chapter 7: Achievements and limitations of cervical cytology screening
Kitchener, H. C., Castle, P. E., & Cox, J. T. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.113 · Cited by 259
High grade cervical lesions are caused preferentially by non‐European variants of HPVs 16 and 18
Sichero, L., Ferreira, S., Trottier, H., Duarte‐Franco, E., Ferenczy, A., Franco, E. L., & Villa, L. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.22481 · Cited by 214
Trottier, H., Mahmud, S., Prado, J. C. M., Sobrinho, J. S., Costa, M. C., Rohan, T. E., Villa, L. L., & Franco, E. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/587698 · Cited by 187
Jagu, S., Karanam, B., Gambhira, R., Chivukula, S. V., Chaganti, R. J., Lowy, D. R., Schiller, J. T., & Roden, R. B. S. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp106 · Cited by 166
Human papillomavirus genotypes in rural Mozambique
Castellsagué, X., Menéndez, C., Loscertales, M., Kornegay, J. R., dos Santos, F., Gómez-Olivé, F. X., Lloveras, B., Abarca, N., Vaz, N., Barreto, A., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06523-0 · Cited by 130
Self-citationMuñóz, N., Hernandez-Suarez, G. A., Méndez, F., Molano, M., Posso, H., Moreno, V. R., Murillo, R., Ronderos, M., Meijer, C. J. L. M., & Muñoz, Á. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604972 · Cited by 129
New Technologies in Cervical Cancer Screening
Gravitt, P. E., Coutlée, F., Iftner, T., Sellors, J. W., Quint, W. G. V., & Wheeler, C. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.002 · Cited by 122
Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
Castle, P. E., Fetterman, B. J., Poitras, N. E., Lorey, T. S., Shaber, R. E., & Kinney, W. (2009) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3181996ffa · Cited by 114
International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence
Maucort‐Boulch, D., Franceschi, S., Plummer, M., & the IARC HPV Prevalence Surveys Study Group (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2691 · Cited by 88
HPV-based cervical cancer screening in a population at high risk for HIV infection
Womack, S. D., Chirenje, Z. M., Gaffikin, L., Blumenthal, P. D., McGrath, J. A., Chipato, T., Ngwalle, S., Munjoma, M. W., & Shah, K. V. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000115)85:2%3c206::aid-ijc10%3e3.0.co;2-q · Cited by 80
Correlates of Cervicovaginal Human Papillomavirus Detection in Perimenopausal Women
Althoff, K. N., Paul, P., Burke, A. E., Viscidi, R. P., Sangaramoorthy, M., & Gravitt, P. E. (2009) · Journal of Women s Health · doi:10.1089/jwh.2008.1223 · Cited by 64
Recent Developments in Computer-Assisted Analysis of Mixtures
Böhning, D., Dietz, E., & Schlattmann, P. (1998) · Biometrics · doi:10.2307/3109760 · Cited by 61
Recommendations for Cervical Cancer Prevention in Latin America and the Caribbean
Muñóz, N., Franco, E. L., Herrero, R., Andrus, J. K., de Quadrós, C. A., Goldie, S. J., & Bosch, F. X. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.05.062 · Cited by 55
Self-citationZhao, C., Elishaev, E., Yuan, K., Yu, J., & Austin, R. M. (2007) · Cancer · doi:10.1002/cncr.22949 · Cited by 33
Cited by
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Global Burden of Human Papillomavirus and Related Diseases
Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J., Ferlay, J., Bray, F., Plummer, M., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.055 · Cited by 1,642
Self-citationGlobal cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Carcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationGuan, P., Howell‐Jones, R., Li, N., Bruni, L., de Sanjosé, S., Franceschi, S., & Clifford, G. M. (2012) · International Journal of Cancer · doi:10.1002/ijc.27485 · Cited by 927
Self-citation
Metadata
- Authors
- Bruni, L., Diaz, M., Castellsagué, X., Ferrer, E., Bosch, F. X., & de Sanjosé, S.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-12-15
- Volume
- 202
- Issue
- 12
- Pages
- 1789-1799
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2103680668
- Cited by
- 1,641
- References
- 33
- FWCI
- 39.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.